D. D. Namazova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
D. D. Namazova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Chernysheva
N.I. Pirogov Russian National Research Medical University Ministry of Health of Russia
1 shared publication - A. L. Rossina
Pirogov Russian National Research Medical University
1 shared publication - A. N. Slatetskaya
Russian Children's Clinical Hospital — Branch of N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
1 shared publication - Elena Efimovna Petryaykina
Pirogov Russian National Research Medical University
1 shared publication - M. S. Rajkovic
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
1 shared publication - Mukhammad A. Sayfullin
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
1 shared publication
Latest Publications
- Open Access
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 22-28
COVID-19 in children with somatic pathology
The coronavirus infection is a pressing issue in modern healthcare, yet the characteristics of the SARS-CoV-2 infection course in children with comorbidities remain insufficiently studied. The aim of this study was to evaluate the clinical form, severity, and duration of SARS-CoV-2 virus shedding in pediatric patients with somatic diseases, depending on the comorbid pathology. Materials and Methods. A comprehensive single-center retrospective study was conducted, analyzing 314 medical records of patients hospitalized in the infectious diseases department of the Russian Children’s Clinical Hospital in Moscow over 11 months in 2022. The inclusion criterion was the presence of a laboratory-confirmed COVID-19 diagnosis. Results. Children with comorbidities were found to be predisposed to a more severe course of SARS-CoV-2 infection compared to the pediatric population in general. Children with hematological diseases were at the highest risk of adverse outcomes from COVID-19. Patients with oncological and hematological diseases and primary immunodeficiencies shed the SARS-CoV-2 virus significantly longer than patients with other somatic pathologies. The duration of SARS-CoV-2 RNA detection in patients with severe COVID-19 was significantly longer, which also correlated with the severity of the underlying somatic disease. Conclusion. Children with comorbidities are at risk for a more severe and prolonged course of SARS-CoV-2 infection.
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 22-28
Open AccessCOVID-19 in children with somatic pathology
The coronavirus infection is a pressing issue in modern healthcare, yet the characteristics of the SARS-CoV-2 infection course in children with comorbidities remain insufficiently studied. The aim of this study was to evaluate the clinical form, severity, and duration of SARS-CoV-2 virus shedding in pediatric patients with somatic diseases, depending on the comorbid pathology. Materials and Methods. A comprehensive single-center retrospective study was conducted, analyzing 314 medical records of patients hospitalized in the infectious diseases department of the Russian Children’s Clinical Hospital in Moscow over 11 months in 2022. The inclusion criterion was the presence of a laboratory-confirmed COVID-19 diagnosis. Results. Children with comorbidities were found to be predisposed to a more severe course of SARS-CoV-2 infection compared to the pediatric population in general. Children with hematological diseases were at the highest risk of adverse outcomes from COVID-19. Patients with oncological and hematological diseases and primary immunodeficiencies shed the SARS-CoV-2 virus significantly longer than patients with other somatic pathologies. The duration of SARS-CoV-2 RNA detection in patients with severe COVID-19 was significantly longer, which also correlated with the severity of the underlying somatic disease. Conclusion. Children with comorbidities are at risk for a more severe and prolonged course of SARS-CoV-2 infection.